Matching‐adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed‐duration venetoclax and ibrutinib in patients with treatment‐naïve chronic lymphocytic leukaemia

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Talha Munir, Leyla Mohseninejad, Pal Rakonczai, Balazs Dobi, Sheng Xu, Keri Yang, Remus Vezan, Nicolás Martinez Calle
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet